Anthos Therapeutics, Inc.

This study is testing whether a new injectable drug called abelacimab can safely prevent strokes and blood clots in people with atrial fibrillation who are at high risk but cannot take standard oral blood thinners. About 1,900 participants will receive either the drug or a placeb…